a phase i clinical trial , like this one , usually only includes a handful of patients , according to the american cancer society . the small trial aims to determine how the body reacts to a new drug and whether patients experience any adverse reactions . phase i trials do not address whether a drug actually works to treat a condition - that question crops up in later trials . as it stands , the crispr study suggests that the new cancer therapy is at least safe for three people , barring more data to come .